Cytestrol acetate

Cytestrol acetate is a synthetic estrogen and progestin medication that was developed for use in hormone replacement therapy (HRT) and the treatment of menopausal symptoms. It is a combination of two active components: estradiol and cyproterone acetate.
Medical Uses[edit]
Cytestrol acetate is primarily used in hormone replacement therapy to alleviate symptoms associated with menopause, such as hot flashes, vaginal atrophy, and osteoporosis. It is also used in the treatment of hormone-sensitive cancers and certain gynecological disorders.
Mechanism of Action[edit]
The medication works by supplementing the body with estrogen and progestin, which are hormones that decrease in production during menopause. Estradiol acts as the estrogen component, while cyproterone acetate serves as the progestin component. This combination helps to balance hormone levels, thereby reducing menopausal symptoms and providing protective effects against osteoporosis.
Side Effects[edit]
Common side effects of cytestrol acetate include nausea, headache, breast tenderness, and weight gain. More serious side effects can include an increased risk of blood clots, stroke, and breast cancer. Patients are advised to discuss potential risks and benefits with their healthcare provider.
Contraindications[edit]
Cytestrol acetate is contraindicated in individuals with a history of breast cancer, endometrial cancer, liver disease, or thromboembolic disorders. It is also not recommended for use during pregnancy or breastfeeding.
Pharmacokinetics[edit]
The pharmacokinetics of cytestrol acetate involve its absorption, distribution, metabolism, and excretion. The medication is typically administered orally and is well-absorbed in the gastrointestinal tract. It undergoes hepatic metabolism and is excreted primarily through the urine.
History[edit]
Cytestrol acetate was developed in the mid-20th century as part of efforts to create effective hormone replacement therapy options. It has been used in various countries for the treatment of menopausal symptoms and other hormone-related conditions.
See Also[edit]
References[edit]
External Links[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian